Friday, September 17, 2021
Farmers Debt Relief

77 shaheed soliders

516 sewa kendras

9300 cr Investment

helpline portal

jallianwala bagh


Markfed Sept to Nov

Innocent Admission

Scientists find drug cocktail effective against Delta, Beta variants

- Advertisement -

Singapore, Aug 2, 2021 – A team of researchers here has found a combination of antiviral and anti-inflammatory drugs that can be used to treat Covid-19 patients with mild to moderate disease.

The team from National University of Singapore (NUS) found that a combination of antiviral molnupiravir and anti-inflammatory baricitinib can be effective against the Beta and Delta variants of the virus, the Strait Times reported.

The combination could strongly inhibit the SARS-CoV-2 virus in laboratory tests, making it suitable for further clinical evaluation, Professor Dean Ho, director of the NUS’s Institute for Digital Medicine, was quoted as saying.

“… we are looking for combination therapies that can eventually be given to patients with mild illness who are recovering at home, or in community care facilities,” Ho said.

Experts from the National Centre for Infectious Diseases, NUS Medicine and the National University Hospital (NUH) tested 12 drugs — which included a range of antivirals and cancer drugs.

The molnupiravir-baricitinib combination was identified for possible treatment, the report said.

However, there is no data yet from clinical trials that show the drug combination is effective in all phases of Covid-19 disease, Dr Louis Chai, a senior consultant at the NUH Division of Infectious Diseases, was quoted as saying.

While some drugs could reduce the Covid viral load in patients, they may not slow down disease progression or prevent death, he noted.

Molnupiravir “interferes with a part of the virus that is conserved across different variants — specifically, the enzyme that it uses to copy its genetic material for replication”, said Dr Conrad Chan, laboratory director at the Defence Medical and Environmental Research Institute from DSO.

Chan molnupiravir “a strong ‘backbone’ drug candidate from which multiple combinations can be derived”, he added.

Ho said his team is now looking to conduct clinical trials for molnupiravir and its drug combinations on Covid-19 patients. Vaccinated individuals with mild to moderate disease could be considered as part of the study cohort, the report said.  (Agency)

Subscribe to YesPunjab Telegram Channel & receive important news updates

- Advertisement -

Yes Punjab - TOP STORIES

Punjab News

Sikh News

Transfers, Postings, Promotions

- Advertisement -spot_img

Stay Connected






Rahul Gandhi Congress Neon

RaGa’s Kashmiri Pandit solidarity may be an assertion for electoral gain – By Deepika Bhan

Thirty-one years after the exodus of Kashmiri Pandits from Kashmir, the Nehru-Gandhi family has for the first time unambiguously spoken up for the community....
Faiz Hameed ISI

Kingmaker of Afghanistan, Pak spy chief Faiz Hameed could be next army chief – by Mrityunjoy Kumar Jha

His Masters Voice (HMV) -- that is how the Chief of Pakistan's spy agency, Inter-Services Intelligence (ISI) is known in his country. Hameed is...

Existential crisis in Lebanon – by Asad Mirza

While the world it seems has been too occupied with the developments in Afghanistan, another tragedy in the making is currently on in Lebanon...


Health & Fitness


Early diagnosis key to cure lymphoma: Doctors

New Delhi, Sep 15, 2021- Proper and timely diagnosis of lymphoma is key and may also cure the disease for life, said doctors on Wednesday. September 15 is observed every year as World Lymphoma Awareness Day. The Mayo Clinic defines lymphoma as a cancer of the lymphatic system -- part of the body's germ-fighting network. The lymphatic system includes the lymph...

Gadgets & Tech

error: Content is protected !!